No CrossRef data available.
Article contents
Intoxicación por escitalopram
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Cartas al director
- Information
- Copyright
- Copyright © European Psychiatric Association 2005
References
Bibliografía
[1] Drewes, P, Thijssen, I, Mengel, H. A single-dose, crossover pharmacokinetic study comparing racemic citalopramm (40 mg) with the Senantiomer of citalopram (escitalopram, 20 mg) in healthy male volunteers. Poster presented at the Annual Meeting of the New Clinical Data Evaluation Unit (NCDEU), Phoenix (AZ) USA. 2001;29 May-1 June.Google Scholar
[2] Gorman, PJ, Kent, JM. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry 1999;60(Suppl 4):33-8.Google ScholarPubMed
[3] Hakkarainen, H, Rienes, EH. Escitalopram and citalopram: safety comparison. Poster presented at the World Congress of Biological Psychiatry (WCBP), Berlin, Germany. 2001; 1–6 July.Google Scholar
[4] Hyttel, J, Bogeso, KP, Perregaard, J. The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer. J Neural Transm Gen Sect 1992;88:157–60.CrossRefGoogle ScholarPubMed
[5] Jonasson, B, Saldeen, T. Citalopram in fatal poisoning cases. Forensic Sci Int 2002;126:1–6.Google ScholarPubMed
[6] Owens, MJ, Knight, DL, Nemeroff, CB. Second generation SSRIs: human monoamin transporter binding profile of essitalopram and Rfluoxetin. Biol Psychiatry 2001;50:345–50.Google Scholar
[7] Personne, M, Persson, H, Sjoberg, E. Citalopram toxicity. Lancet 1997;350:518–9.CrossRefGoogle ScholarPubMed
You have
Access